General Range
F-MOXI 400
Price on request/100 · MOQ 100 boxes
F-MOXI 400 Tablets by Fortune Labs contain Moxifloxacin Hydrochloride 400 mg, a broad-spectrum fluoroquinolone antibiotic used to treat certain bacterial infections. This prescription medicine works by inhibiting bacterial enzymes necessary for DNA replication, helping prevent bacterial growth. Moxifloxacin may be prescribed for selected respiratory tract infections, community-acquired pneumonia, and certain skin infections when clinically appropriate. F-MOXI 400 is available in convenient 10 × 1 × 5 tablet packaging. Fortune Labs offers this antibiotic formulation to authorized pharmaceutical distributors and PCD Pharma Franchise partners across India. Contact Fortune Labs for wholesale pricing, product availability, and distribution opportunities. Due to potentially serious adverse effects, including tendon injury and nerve damage, use only under medical supervision.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Moxifloxacin Hydrochloride 400 mg
- Packaging Type
- Blister Pack
- Packaging Size
- 10 × 1 × 5
- Dosage Form
- Tablet
- Treatment
- Bacterial respiratory tract infections, community-acquired pneumonia, acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis,
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
